With regard to LPI (the endogenous GPR55 agonist), both LPI 18:0 and LPI with an arachidonic acid moiety (20:4) showed higher levels in IBD in comparison to control subjects (Fig. 1f–g). The gene discussed is GPR55; the disease is inflammatory bowel disease.